The annual Forbes franchise valuation article is out and, not surprisingly, the Yankees are considered the most valuable baseball team. They’re worth $2.5 billion, to be inexact. And, yes, while Forbes takes maybe the boldest stab at such things each year, pegging how much money closely-held businesses — many of them family businesses — which notoriously hide the ball as to financial matters make or lose this exercise is an inexact science.
With that caveat in mind, guess the most profitable. Give up? It’s the Cardinals, who an operating income of $65.2 million. I wouldn’t have guessed that given their market size and not-so-great TV deal, but there you go. More surprising: the Astros were second at $55.9 million. Which tells you what a low payroll will do for you. Indeed, going up and down the list of operating income and you see all manner of surprising things, actually. But then you have to remember that team owners do things like create management companies consisting of the owners and their families as a means of taking untold amounts of money from the club and putting it in their pockets, and you realize that these guys can make the numbers do anything they’d like.
Still, fun stuff. A nice snapshot, but not much more. There just isn’t enough data out there for anyone to check these numbers and the only people in a position to correct them — the owners themselves — wouldn’t dare reveal what they really make or lose.
The Cleveland Indians just announced that they’ve acquired catcher Chris Gimenez from the Texas Rangers in exchange for cash considerations.
Gimenez knows his way to Progressive Field. Indeed, this will be his third stint with the Indians organization. He was their 19th round pick in the 2004 draft, made his big league debut with the club in 2009 and stayed through the 2010 season. He came back in 2014 for eight games, now he’s back again. He has yet to play in 2016 due to a ankle issue. He as doing minor league rehab before being DFA’d by the Rangers yesterday.
Come back to Cleveland, Chris. You always will have a home in Cleveland.
Last year the Dodgers suspended infielder Erisbel Arruebarrena for the remainder of the season“for repeated failures to comply with his contract.” Arreubarrena appealed his suspension to Major League Baseball and it was reduced to thirty days, though that was said to be a settlement between Arruebarrena and the Dodgers as opposed to a full adjudication.
Here we go again: Gabe Kapler, the Dodgers Director of Player Development, just announced that the Dodgers have suspended Arruebarrena for the rest of 2016 “for repeated failure to comply with the terms of his contract.” No further specifics were given.
Arruebarrena was signed out of Cuba to to a five-year, $25 million deal back in 2013. He played in 22 games in the bigs in 2014, hitting .195. He was dropped from the 40-man roster after that season, however, and after his suspension last year managed to only play in 53 games across three levels. He hit better, but none of his action was above Double-A and he was 25 at the time. He’s played 17 games at Double-A this year and isn’t hitting.
What he was or was not doing with respect to his contract is unclear at the moment, but this isn’t exactly the kind of thing that happens on a daily basis, especially with dudes under contract for $25 million, so we’ll probably hear more eventually.
NEW YORK (AP) Braves right fielder Nick Markakis has left the team because of a family emergency.
Manager Fredi Gonzalez said before Wednesday’s game against the Mets that Markakis had headed home to Maryland. The veteran is expected to be back in time for Friday’s home game against Arizona. Atlanta is off Thursday.
Chase d’Arnaud is starting in right field and Mallex Smith is leading off Wednesday.
Markakis is hitting .281 with no home runs and 20 RBIs.
T.J. Quinn of ESPN’s Outside the Lines reports that another major leaguer — or possibly several of them — will soon be suspended for PEDs. He says that, as was the case with Chris Colabello and others recently, the drug will be Turinabol, which is an old school anabolic steroid. Quinn says that improved testing procedures, which he details in the article, are a likely reason for the spike in Turinabol positives, though it’s also possible that there is a tainted supplement being taken, though he deems that speculative.
What isn’t mentioned is . . . how an ESPN reporter knows a positive test is coming when the drug testing program is supposed to be confidential. Someone with the league or the union must be telling him, right? That’s sort of messed up, no? Will MLB investigate who is leaking such things?
Whatever the case, we’ll soon have a new police blotter item, it seems.